# Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

> **NCT01978938** · PHASE3 · COMPLETED · sponsor: **Tetraphase Pharmaceuticals, Inc** · enrollment: 908 (actual)

## Conditions studied

- cUTI

## Interventions

- **DRUG:** Eravacycline
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT01978938
- **Lead sponsor:** Tetraphase Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-06
- **Primary completion:** 2015-06-03
- **Final completion:** 2015-08-21
- **Target enrollment:** 908 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01978938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01978938, "Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01978938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*